Effects of Early MSC Intervention on Preventing the Streptozotocin-Induced T1DM Progression in Mice

Figure 2

Mesenchymal stem cell infusion reduces the pathological damage to T1DM mice. H&E staining (a) and IHC staining (b) of islets on the 56^th day of each group. Masson’s trichrome staining of the glomerulus on the 56^th day of each group (c). The quantitative real-time PCR of TGF-β1 expression (d) and Collagen I expression (e) in the kidney. Scale bars: (a–c) 200 μm.